High Rate of Virological Response to Peginterferon α-2a–Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C

BACKGROUND: Hepatitis C is a major reason of morbidity and mortality among hemophilia patients. Although combination therapy with peginterferon (peg-INF) and ribavirin is considered as standard treatment for chronic hepatitis C (CHC), but more evidence of the efficacy and safety is needed. OBJECTIVE...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Alavi Moghaddam, Mostafa, Zali, Mohammad Reza, Aalaei Andabili, Seyed Hossein, Derakhshan, Faramarz, Miri, Seyed Mohammad, Alavian, Seyed Moayed
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Kowsar 2012
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3470839/
https://ncbi.nlm.nih.gov/pubmed/23105981
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन